Intellectual property (IP) protections, including patents, are the foundation for biopharmaceutical innovation and the development of new treatments, cures and vaccines for patients. A strong IP system is what has allowed the American biopharmaceutical industry to become the world leader in new medicine development and has allowed us to make unprecedented strides in treating everything from acute leukemia to hepatitis C and more.
We created a short video to explain how our IP system:
- Lays the foundation for new treatments, cures and vaccines for patients
- Promotes competition
- Drives down health care costs by paving the way for generics
To learn more about the role IP plays in the biopharmaceutical industry, follow our IP Explained blog series.